Digesting it all

| Teresa Miceli

As I return home from the 58th annual American Society of Hematology meeting, there is so much information to digest and process. It was like a cornucopia of data. The #daratumumab information was plentiful – from the Castor and Pollux studies achieving Food and Drug Administration approval for use with Velcade + Dex or Revlimid […]

Treatment advances provide many lily pads

| Linda Huguelet

When I was diagnosed with myeloma in 2010, a huge concern of mine was the limited number of treatment options. Although the currently available options were far superior to those available just a decade prior, there was still a limited universe of treatment paths. I keenly remember one of my first visits to Vanderbilt Medical […]